Another group recently interrogated 148 lung neuroendocrine tumors, including 33 SCLC, and demonstrated the prevalence of TP53 and RB1 while suggesting significant roles for chromatin-remodeling genes in lung neuroendocrine pathogenesis [11]. Here, TP53 is linked to small cell lung carcinoma.